RxDoctor Payments Data

Brent North, PA

Physician Assistant · Victorville, CANPI 1104155761

Payments from drug & device makers

$1,671in general payments, 2019–2025

Across 85 payments — averaging $19.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$330
  • Abbott$229
  • Novo Nordisk$157
  • Merck$153
  • AstraZeneca$102
  • Exact Sciences$97
  • plus $604 from 16 others

What the payments were for

  • Food & beverage$1,63898%
  • Education$322%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,671 in reported general payments places this provider in the 80th percentile of 10,423 physician assistant providers in California.

See all physician assistant providers in California

Medicare billing

Part B allowed, 2024
$12,422
Medicare patients
57
Services billed
136

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide118$129,924
Trelegy ElliptaFluticasone/Umeclidin/Vilanter71$50,498
EliquisApixaban41$39,512
JardianceEmpagliflozin35$30,069
Soliqua 100-33Insulin Glargine/Lixisenatide21$25,335
TrulicityDulaglutide16$22,585
MounjaroTirzepatide24$22,581
JanuviaSitagliptin Phosphate15$21,800
FarxigaDapagliflozin Propanediol26$20,532
RybelsusSemaglutide15$19,576
XareltoRivaroxaban17$16,978
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr39$16,700
Breo ElliptaFluticasone/Vilanterol26$14,366
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog14$12,150
Atorvastatin Calcium430$3,965

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$157$149,501133 claims
GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta$18$81,564136 claims
Lilly USA, LLCTrulicity, Mounjaro$330$45,16640 claims
Boehringer IngelheimJardiance$19$30,06935 claims
MerckJanuvia$153$21,80015 claims
AstraZenecaFarxiga$102$20,53226 claims
Johnson & JohnsonXarelto$26$16,97817 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 10,423 physician assistant providers in California.

Other physician assistant in Victorville

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →